Robotic Percutaneous Coronary Intervention During COVID-19 Pandemic: Outcomes and Cost Effectiveness With Procedural Distancing

被引:0
|
作者
Sooknanan, Naveen N. [1 ]
Memon, Sehrish [2 ]
George, Jon C. [2 ]
机构
[1] Einstein Med Ctr, Div Internal Med, Philadelphia, PA 19141 USA
[2] Einstein Med Ctr, Div Cardiovasc Dis, Philadelphia, PA 19141 USA
来源
JOURNAL OF INVASIVE CARDIOLOGY | 2022年 / 34卷 / 02期
关键词
COVID-19; percutaneous coronary intervention; robotic-assisted PCI; FEASIBILITY; SAFETY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. The COVID-19 pandemic raised many questions, including the need to maintain distancing and the importance of full personal protection equipment (PPE) for healthcare workers. Robotic-assisted percutaneous coronary intervention (R-PCI) can be advantageous during a pandemic to facilitate procedural distancing for cath lab personnel and to decrease the cumulative amount of PPE employed. Methods. All patients who underwent R-PCI during the early phase of the pandemic were evaluated at a single institution. Procedural characteristics, complexity of disease, and use of adjunctive imaging or physiology were queried. Mean R-PCI time, procedure and fluoroscopy times, radiation dose, and contrast volume were collected. Cost of PPE incurred with R-PCI was evaluated in comparison with traditional cases. Furthermore, procedural distancing from patients for operators was objectively quantified to compare with traditional cath lab cases. Results. Thirteen patients were treated using R-PCI. Radial access site was utilized in 54% and the left circumflex artery was treated most frequently (in 50% of cases). The complexity of cases performed was illustrated by revascularization of chronic total occlusions in 2 patients (14%) as well as adjunctive intravascular ultrasound or instantaneous wave-free ratio in 4 patients (29%). Mean R-PCI time was 45.38 minutes, manual time was 25.66 minutes, and total procedure time was 71.08 minutes. Average fluoroscopy time was 18.27 minutes, contrast volume was 143.85 mL, and radiation dose was 747.15 mGy. R-PCI was more cost effective, with total average PPE cost of $330.71 in comparison with $496.08 for traditional PCI (absolute difference, $165.36). Furthermore, R-PCI demonstrated substantial procedural distancing of operators from patients (8.14 feet for R-PCI vs 2.75 feet for traditional PCI; absolute difference, 5.39 feet). Conclusion. R-PCI could be a promising strategy during a pandemic by facilitating procedural distancing, minimizing staffing exposure risk, and decreasing PPE cost.
引用
收藏
页码:E87 / E91
页数:5
相关论文
共 50 条
  • [1] Trends and outcomes of percutaneous coronary intervention during the COVID-19 pandemic in Michigan
    Azzalini, Lorenzo
    Seth, Milan
    Sukul, Devraj
    Valle, Javier A.
    Daher, Edouard
    Wanamaker, Brett
    Tucciarone, Michael T.
    Zaitoun, Anwar
    Madder, Ryan D.
    Gurm, Hitinder S.
    [J]. PLOS ONE, 2022, 17 (09):
  • [2] Robotic-assisted percutaneous coronary intervention in the COVID-19 pandemic
    Yamaji, Kazunori
    Mitsutake, Yoshiaki
    Nakano, Masaharu
    Nakamura, Takuya
    Fukumoto, Yoshihiro
    [J]. JOURNAL OF CARDIOLOGY, 2022, 79 (04) : 455 - 459
  • [3] Utilization of Percutaneous Coronary Intervention During the COVID-19 Pandemic
    Heaton, Joseph
    Udongwo, Ndausung
    Mararenko, Anton
    Imburgio, Steve
    Johal, Anmol
    Singh, Sohrab
    Asif, Arif
    Sealove, Brett
    Almendral, Jesus
    Selan, Jeffrey
    [J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2023, 51 : 75 - 76
  • [4] Stormy Primary Percutaneous Coronary Intervention During COVID-19 Pandemic
    Lim, Wei Juan
    Loh, Hoong Sheng
    Beh, Ting Yuen
    Kandasamy, Balachandran
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (15) : S79 - S81
  • [5] Robotic-assisted percutaneous coronary intervention in a COVID-19 patient
    Tabaza, Luai
    Virk, Hafeez ul Hassan
    Janzer, Sean
    George, Jon C.
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 97 (03) : E343 - E345
  • [6] Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic
    Mohammad, Moman A.
    Koul, Sasha
    Olivecrona, Goran K.
    Gotberg, Matthias
    Tyden, Patrik
    Rydberg, Erik
    Schersten, Fredrik
    Alfredsson, Joakim
    Vasko, Peter
    Omerovic, Elmir
    Angeras, Oskar
    Frobert, Ole
    Calais, Fredrik
    Volz, Sebastian
    Ulvenstam, Anders
    Venetsanos, Dimitrios
    Yndigegn, Troels
    Oldgren, Jonas
    Sarno, Giovanna
    Grimfjard, Per
    Persson, Jonas
    Witt, Nils
    Ostenfeld, Ellen
    Lindahl, Bertil
    James, Stefan K.
    Erlinge, David
    [J]. HEART, 2020, 106 (23) : 1812 - 1818
  • [7] Triage for Potential Percutaneous Coronary Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic
    Liu, Qi
    He, Sen
    Xiong, Tian-Yuan
    Peng, Yong
    Wei, Jia-Fu
    Li, Chen
    Zhu, Ye
    Zhang, Li
    Wang, Mian
    Wang, Hua
    Zheng, Ming-Xia
    Bao, Yun
    Wang, Ya-Li
    He, Yong
    Chen, Mao
    [J]. FRONTIERS IN MEDICINE, 2020, 7
  • [8] The impact of the COVID-19 pandemic on the delivery of primary percutaneous coronary intervention in STEMI
    Frain, Kristina
    Rathod, Krishnaraj S.
    Tumi, Ebrahiem
    Chen, Yang
    Hamshere, Stephen
    Choudry, Fizzah
    Akhtar, Mohammed M.
    Curtis, Miles
    Amersey, Rajiv
    Guttmann, Oliver
    O'Mahony, Constantinos
    Jain, Ajay
    Wragg, Andrew
    Baumbach, Andreas
    Mathur, Anthony
    Jones, Daniel A.
    Rees, Paul
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DISEASE, 2021, 11 (05): : 647 - 658
  • [9] Mortality after cardiovascular surgery and percutaneous coronary intervention prior to versus during the COVID-19 pandemic
    Chu, A.
    Wang, X.
    Paterson, J. M.
    Hillmer, M.
    Malikov, K.
    Lee, D. S.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [10] Health-related quality of life following percutaneous coronary intervention during the COVID-19 pandemic
    Luke P. Dawson
    Diem T. Dinh
    Dion Stub
    Susannah Ahern
    Jason E. Bloom
    Stephen J. Duffy
    Jeffrey Lefkovits
    Angela Brennan
    Christopher M. Reid
    Ernesto Oqueli
    [J]. Quality of Life Research, 2022, 31 : 2375 - 2385